U.S. Markets closed

Thermo Fisher Scientific Inc. (TMO)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
175.47-0.13 (-0.07%)
At close: 4:00PM EDT

175.47 0.00 (0.00%)
After hours: 4:34PM EDT

People also watch
WATPKISYKDHRSTJ

Thermo Fisher Scientific Inc.

68 Third Avenue
Waltham, MA 02451
United States
781-622-1000
http://www.thermofisher.com

SectorHealthcare
IndustryMedical Laboratories & Research
Full Time Employees55,000

Key Executives

NameTitlePayExercisedAge
Mr. Marc N. CasperChief Exec. Officer, Pres and Director6.12M10.32M49
Mr. Stephen WilliamsonChief Financial Officer and Sr. VP1.44M2.53M50
Mr. Thomas W. LoewaldChief Commercial Officer and Sr. VP1.52M2.17M53
Mr. Mark P. StevensonExec. VP and Pres of Life Sciences Solutions2.41MN/A54
Mr. Peter E. HornstraChief Accounting Officer and VPN/AN/A57
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems to support clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers controlled temperature technology products; sample preparation and preservation equipment; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; and research and safety market channel, and biopharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

Corporate Governance

Thermo Fisher Scientific Inc.’s ISS Governance QualityScore as of June 2, 2017 is 4. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 4; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.